Skip to search formSkip to main contentSkip to account menu

Non-Q wave myocardial infarction

Known as: non q wave myocardial infarction, infarction myocardial non q wave, nqmi 
National Institutes of Health

Related topics

Related topics

9 relations
Acute myocardial infarctionArteriosclerosisCardiovascular systemsubendocardial heart attack

Broader (5)

Coronary ArteriosclerosisCoronary Artery DiseaseCoronary heart diseaseMyocardial Infarction

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
High-risk coronary atheroma: the interplay between ischemia, plaque burden, and disease progression.
Review
2001
Review
2001
Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety.
Abbreviations: ACT 5 activated clotting time; APTT 5 activated partial thromboplastin time; AT 5 antithrombin; AT-III 5… 
2001
2001
Dynamic changes of QT interval and QT dispersion in non-Q-wave and Q-wave myocardial infarction.
QT interval and QT dispersion both prolong early postinfarction. Non-Q wave (NQMI) and Q-wave myocardial infarction (QMI) differ… 
Highly Cited
2000
Highly Cited
2000
Evidence of prolonged inflammation in unstable angina and non-Q wave myocardial infarction.
Review
2000
Review
2000
Guidelines for the diagnosis and management of unstable angina and non-Q-wave myocardial infarction: Proposed revisions
Highly Cited
1999
Highly Cited
1999
Enoxaparin prevents death and cardiac ischemic events in unstable angina/non-Q-wave myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) 11B trial.
BACKGROUND Low-molecular-weight heparins are attractive alternatives to unfractionated heparin (UFH) for management of unstable… 
Review
1999
Review
1999
Q-wave versus non-Q wave myocardial infarction: a meaningless distinction.
Highly Cited
1999
Highly Cited
1999
Independent prognostic value of C-reactive protein and troponin I in patients with unstable angina or non-Q-wave myocardial infarction.
Review
1998
Review
1998
Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety.
Abbreviations: ACT 5 activated clotting time; APTT 5 activated partial thromboplastin time; AT 5 antithrombin; AT-III 5… 
Review
1997
Review
1997
The non-Q wave myocardial infarction revisited: 10 years later.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)